Rhabdomyosarcoma Clinical Trials

A listing of Rhabdomyosarcoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Massachusetts

UPDATED

Boston Massachusetts 02215

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Texas

UPDATED

Houston Texas 77030

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Wisconsin

UPDATED

Madison Wisconsin 53792

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Austria

UPDATED

Wien 1090

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Canada

UPDATED

Toronto Ontario M5G 1X8

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Denmark

UPDATED

København Ø 2100

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Faroe Islands

UPDATED

Toulouse 31059

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

France

UPDATED

Bordeaux 33076

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Lille 59020

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Lyon 69008

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Paris 75248

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Villejuif 94805

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Germany

UPDATED

Aachen

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Essen 45147

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Freiburg

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Goettingen

A Phase 1/Phase 2 clinical study for patients with Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma or Non-Rhabdomyosarcoma Soft Tissue Sarcoma

UPDATED

Tübingen 72076

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Italy

UPDATED

Genova 16147

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Milano 20133

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Padova 35128

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Roma 00165

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Netherlands

UPDATED

Rotterdam 3015 CN

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

Spain

UPDATED

Barcelona 08035

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

United Kingdom

UPDATED

Birmingham B4 6NH

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma

UPDATED

Sutton SM2 5PT

A clinical research study of Afatinib for the treatment of Neuroectodermal Tumors or Rhabdomyosarcoma